REBA GOSHERT: Open Payments
NPI 1912103151 · NAPPANEE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$358 in 21 payments from 10 companies in 2025. Trend: 2023 $789 · 2024 $533 · 2025 $358
Food & beverage: $358
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $102 |
| ABBVIE INC. | 3 | $50 |
| PFIZER INC. | 3 | $42 |
| Lundbeck LLC | 2 | $34 |
| Lilly USA, LLC | 2 | $32 |
| Edwards Lifesciences Corporation | 1 | $25 |
| Exact Sciences Corporation | 1 | $22 |
| Novo Nordisk Inc | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
Products named: AIRSUPRA, VRAYLAR, REXULTI, PREVNAR 20, Edwards SAPIEN 3 Ultra Transcatheter Heart Valve, Cologuard Collection Kit, Ozempic, BREZTRI.
Industry payments across IN — which companies pay providers there.
